Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06434597
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-05-23
Brief Title:
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positiveMutated Biliary Tract OR Colorectal Cancer Patients
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Organization Data
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Class:
INDUSTRY
Study ID:
SPH5030-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None